Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amylin Pharmaceuticals May Have a Great Shot
Barron's
Friday, February 26, 2010 - 8:31am
tags:
Amylin, exanitide
Merck Puts Up Its Asset-Sale Shingle
InVivo
Friday, February 26, 2010 - 8:27am
tags:
Merck, licensing
Ranbaxy Shares Fall on Earnings Forecast, FDA Issues
Bloomberg
Friday, February 26, 2010 - 8:26am
tags:
Ranbaxy, earnings
WuXi Pharma COO Highlights Planned Growth
Seeking Alpha
Friday, February 26, 2010 - 8:23am
tags:
China, WuXi PharmaTech
Glaxo Strikes Back at Drug Critics, But It's a Big Swing... and a Miss
BNET Pharma
Thursday, February 25, 2010 - 4:18pm
tags:
GSK, Avandia
Pfizer Experimental Bone Drug Shows Mixed Results In Study
WSJ Online
Thursday, February 25, 2010 - 4:15pm
tags:
Pfizer, Fablyn
FDA says Bristol-Myers kidney transplant drug extends life, but carries side effects
Yahoo/AP
Thursday, February 25, 2010 - 4:15pm
tags:
FDA, kidney transplant, Bristol-Myers Squibb
These Drugs Generated Most Adverse Event Reports
Pharmalot
Thursday, February 25, 2010 - 10:13am
tags:
adverse events
Adolor narrows 4Q loss as Entereg sales increase
Yahoo/AP
Thursday, February 25, 2010 - 10:12am
tags:
Adolor, earnings, Entereg
HGSI Pipeline Bigger than Earnings
Yahoo/Zacks.com
Thursday, February 25, 2010 - 10:11am
tags:
Human Genome Sciences, earnings, Novartis, GSK
Aveo Pharma ups targeted range for IPO
Bizjournals.com
Thursday, February 25, 2010 - 10:10am
tags:
Aveo Pharmaceutical, IPOs, cancer
Ranbaxy Swings To Fourth Quarter Net Profit; Generic Sales Help
WSJ Online
Thursday, February 25, 2010 - 9:22am
tags:
Ranbaxy, generics, earnings
Sanofi-Aventis Layoffs Coming In Dribs And Drabs
Pharmalot
Thursday, February 25, 2010 - 9:13am
tags:
Sanofi, layoffs
Ties To Glaxo Led To Favorable Avandia Studies
Pharmalot
Thursday, February 25, 2010 - 9:07am
tags:
GSK, Avandia
Anadys study results show little difference between hepatitis C drug, placebo; shares slide
Yahoo/AP
Thursday, February 25, 2010 - 9:06am
tags:
hepatitis C, Anadys
Shire gets fast-track status for Replagal from FDA
Pharma Times, UK
Thursday, February 25, 2010 - 9:05am
tags:
FDA, fast track, Shire, Replagal, Fabry's disease
Mylan reports 4Q profit on generic drug sales
Yahoo/AP
Thursday, February 25, 2010 - 9:04am
tags:
generics, Mylan, earnings
Lilly Chief Tests Assembly-Line Drug Hunt to Offset Sales Loss
Bloomberg
Thursday, February 25, 2010 - 9:02am
tags:
Eli Lilly, Pharma CEOs, John Lechleiter, patents, Zyprexa
Roche’s Avastin Drug Stalls Ovarian Cancer in Study
Bloomberg
Thursday, February 25, 2010 - 9:01am
tags:
ovarian cancer, Roche, Avastin
King Pharmaceuticals 4Q profit misses expectations
Yahoo/AP
Thursday, February 25, 2010 - 9:00am
tags:
King, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.